You are viewing: Mexico Pharmaceutical Membrane Filtration Market analysis

The Mexico Pharmaceutical Membrane Filtration Market was valued at $96.7 Million in 2024 and projected to reach to $155.8 Million by 2029, representing a compound annual growth rate of 10.0%. Mexico's pharmaceutical membrane filtration market is poised for sustained growth as the country consolidates its position as a regional pharmaceutical manufacturing powerhouse.

Mexico Pharmaceutical Membrane Filtration Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Pharmaceutical Membrane Filtration Market Trends and Insights

  • This 10.0% compound annual growth rate reflects Mexico's strengthening position in Latin American pharmaceutical manufacturing and biopharmaceutical production.
  • Mexico's strategic location, regulatory alignment with international standards, and growing investment in pharmaceutical infrastructure are driving adoption of advanced filtration technologies across drug manufacturing, biologics processing, and quality assurance applications. The market in Mexico is supported by increasing demand for sterile drug formulations, heightened regulatory compliance requirements, and expansion of contract manufacturing organizations (CMOs) serving both domestic and export markets.
  • Mexico's pharmaceutical sector continues to modernize its production capabilities, with membrane filtration systems becoming essential for meeting stringent quality standards in both small-molecule and biopharmaceutical manufacturing.
  • Between 2024 and 2029, Mexico is expected to see accelerated investment in filtration infrastructure as companies scale operations to meet growing regional and North American demand..

Key Market Statistics

  • CAGR (2024-2029) 10.0% CAGR
  • Market Size, 2024 ~USD 96.7 Million
  • Forecast, 2029 ~USD 155.8 Million
  • Country Mexico

Mexico Pharmaceutical Membrane Filtration Market Overview

Market Valuation Growth :

Mexico's pharmaceutical membrane filtration market is valued at USD 96.7 million in 2024, with projections reaching USD 155.8 million by 2029, representing a robust 10% CAGR driven by increased biopharmaceutical manufacturing investments.

Latin American Manufacturing Hub :

Mexico's strategic geographic position and regulatory alignment with international standards position it as a key pharmaceutical manufacturing center in Latin America, attracting foreign direct investment in filtration technologies.

Biopharmaceutical Production Expansion :

Growing biopharmaceutical production capabilities in Mexico are driving demand for advanced membrane filtration solutions, particularly for protein purification, vaccine manufacturing, and sterile processing applications.

Regulatory Compliance Drivers :

Strengthened pharmaceutical regulations and quality standards in Mexico are compelling manufacturers to adopt advanced membrane filtration systems to meet international GMP and FDA compliance requirements.

Mexico Pharmaceutical Membrane Filtration Market Dynamics

  • The 10% CAGR through 2029 reflects increasing investments in biopharmaceutical infrastructure, contract manufacturing organizations (CMOs), and domestic pharmaceutical production capacity.
  • Mexico's proximity to North American markets, combined with competitive labor costs and regulatory harmonization, continues to attract multinational pharmaceutical companies seeking nearshoring opportunities. The market outlook is further strengthened by Mexico's expanding capabilities in advanced therapeutics, including monoclonal antibodies and biosimilars, which require sophisticated membrane filtration technologies.
  • Government initiatives supporting pharmaceutical innovation and manufacturing modernization are expected to accelerate adoption of membrane filtration systems across small, medium, and large-scale pharmaceutical producers throughout the country..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Key Takeaways

      • Mexico's pharmaceutical membrane filtration market is valued at USD 96.7 million in 2024 and will reach USD 155.8 million by 2029, growing at a 10.0% CAGR.
      • Mexico's strategic geographic position and regulatory framework make it an attractive hub for pharmaceutical manufacturing, driving membrane filtration technology adoption.
      • Expansion of contract manufacturing organizations and biopharmaceutical facilities in Mexico is accelerating demand for advanced filtration solutions between 2024 and 2029.
      • Mexico's pharmaceutical sector modernization and compliance with international quality standards are key drivers of membrane filtration market growth through 2029.

      Pharmaceutical Membrane Filtration Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment POLYETHERSULFONE MEMBRANE FILTERS (Type)
      Forecast Period 2024–2029
      Growth Rate CAGR of 13.1% from 2024 to 2029
      Largest Segment MEMBRANE FILTERS (Product)
      Market Size Base Year (Billions) ~USD 10.59 (2024)
      Revenue Forecast (Billions) ~USD 19.6 (2029)
      Segments Covered Product, Type, Technique, Application, Scale Of Operation

      Mexico Pharmaceutical Membrane Filtration Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Membrane Filters
      • Other Products
      • Systems

      By Type

      • Accessories
      • Active Pharmaceutical Ingredient Filtration
      • Bioburden Testing
      • Formulation And Filling Solutions
      • Media And Buffer Filtration
      • Membrane Filtration Assemblies
      • Mixed Cellulose Ester & Cellulose Acetate Membrane Filters
      • Non-Sterile Filtration
      • Nylon Membrane Filters
      • Other Membrane Filters
      • Polycarbonate Track-Etched Membrane Filters
      • Polyethersulfone Membrane Filters
      • Polytetrafluoroethylene Membrane Filters
      • Polyvinylidene Difluoride Membrane Filters
      • Prefiltration
      • Protein Purification
      • Reusable Systems
      • Single-Use Systems
      • Sterile Filtration
      • Vaccine And Antibody Processing
      • Viral Clearance

      By Technique

      • Microfiltration
      • Nanofiltration
      • Other Techniques
      • Ultrafiltration

      By Application

      • Air Purification
      • Cell Separation
      • Final Product Processing
      • Raw Material Filtration
      • Water Purification

      By Scale Of Operation

      • Manufacturing Scale
      • Pilot Scale
      • R&D Scale

      MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029

      Segment20222023202420252026202720282029CAGR (%)
      AIR PURIFICATION8.38.48.38.48.79.210115.9
      CELL SEPARATION17.418.118.519.420.722.625.429.19.5
      FINAL PRODUCT PROCESSING44.646.74850.654.56067.778.110.2
      RAW MATERIAL FILTRATION34.836.23738.941.845.851.459.19.8
      WATER PURIFICATION14.915.515.716.417.519.121.424.49.2
      TOTAL120.1125127.5133.7143.2156.8175.7201.79.6

      Target Audience

      • Pharmaceutical Manufacturers : Mexican and multinational pharmaceutical companies require market intelligence to optimize filtration technology investments, improve production efficiency, and ensure compliance with evolving Mexican and international regulatory standards.
      • Contract Manufacturing Organizations (CMOs) : CMOs operating in Mexico need detailed market data to benchmark their filtration capabilities, identify technology upgrade opportunities, and understand competitive positioning within Mexico's growing contract manufacturing sector.
      • Filtration Equipment Suppliers : Membrane filtration technology vendors and equipment manufacturers need Mexico-specific market insights to develop localized sales strategies, identify customer segments, and forecast demand for filtration solutions in the Mexican market.
      • Private Equity & Investment Firms : Investment professionals evaluating pharmaceutical and biotech opportunities in Mexico require comprehensive market data to assess growth potential, identify acquisition targets, and evaluate returns in the Mexican filtration market.
      • Regulatory & Compliance Consultants : Consultants advising pharmaceutical companies on Mexican operations need market-specific regulatory insights and compliance requirements to guide clients through Mexico's pharmaceutical manufacturing and quality standards landscape.

      Key Companies in the Mexico Pharmaceutical Membrane Filtration Market

      CompanyHQOwnershipStrongest segments
      VALMET CORPORATIONFinlandPublic CompanyBiomaterial Solutions and Services (pulp, paper, tissue, packaging lines and lifecycle services),Process Performance Solutions – Automation systems and industrial applications,Process Performance Solutions – Flow control (valves, pumps, valve automation),
      MERCK KGAAUnited StatesPublic CompanyLife Science (reagents, consumables, devices, instruments, software, services, bioprocessing solutions, CDMO/testing),Healthcare (prescription drugs and biopharmaceuticals across oncology, rare diseases, neurology and immunology, fertility, cardiovascular, metabolic and endocrinological disorders),Electronics (semiconductor materials, specialty gases, delivery equipment, display and photonics materials),
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (Bioprocessing and Single-Use Solutions),Life Sciences (Instruments and Consumables),Diagnostics (Clinical Instruments and Consumables),
      SARTORIUS AGUnited StatesPublic CompanyBioprocess solutions (bioreactors, cell culture, process filtration & chromatography, fluid management),Lab products & services (lab filtration, weighing, pipettes, microbiological testing, lab water, OEM),Analytical & cell analysis solutions (BLI, cytometry screening, PAT & data analytics, live-cell imaging, SPR, cell selection),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions (reagents, instruments, consumables),Analytical Instruments,Specialty Diagnostics,
      3M COMPANYUnited StatesPublic CompanySafety and Industrial,Transportation and Electronics,Consumer,
      PARKER HANNIFIN CORPORATIONUnited StatesPublic CompanyIndustrial motion and control (hydraulics, pneumatics, electromechanical),Sealing, adhesives, and thermal management,Filtration and fluid management,
      REPLIGEN CORPORATIONUnited StatesPublic CompanyFiltration and cell retention (XCell ATF, TangenX, KrosFlo, TFDF, ProConnex),Chromatography systems, columns, and resins (OPUS, KRM, resins, AVIPure),Process analytics and PAT (PATsmart MAVERICK/MAVEN/REBEL/ZipChip, SoloVPE/FlowVPE),
      ASAHI KASEI CORPORATIONJapanPublic CompanyAdvanced materials for semiconductors and electronics,Battery separators and energy-related materials,Membranes and process systems,
      EATON CORPORATION PLCIrelandPublic CompanyElectrical Americas,Electrical Global,Aerospace,
      GEA GROUPGermanyPublic CompanySeparation & Flow Technologies (separators, decanters, valves, pumps, homogenizers),Liquid & Power Technologies (brewing, liquid processing, filling, concentration, fermentation),Food & Health Technologies (meat, poultry, seafood, vegan processing; slicing; pharma equipment),
      CORNING INCORPORATEDUnited StatesPublic CompanyOptical communications (fiber, cable, hardware, components),Display glass substrates (LCD and OLED),Specialty materials (mobile, semiconductor optics, sunglasses, shielding),
      DONALDSON COMPANY, INC.United StatesPublic CompanyMobile Solutions,Industrial Solutions,Life Sciences,
      SAINT-GOBAINFrancePublic CompanyPlasterboard and interior systems (Placo, Rigips, Gyproc, ceilings brands),Insulation solutions (Isover, CertainTeed, Izocam),Mortars and construction chemicals (Weber, Chryso, GCP),

      VALMET CORPORATION

      Valmet Corporation is a Finnish public company founded in 1750 with 18,370 employees. The company has a long-established history in industrial manufacturing and services.

      MERCK KGAA

      Merck KGaA is a United States-based public company with roots dating to 1668 and 59,077 employees. The company operates as a diversified pharmaceutical and chemical enterprise.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates across multiple industrial and life sciences sectors.

      SARTORIUS AG

      Sartorius AG is a United States-based public company founded in 1870 with 14,242 employees. The company specializes in laboratory and pharmaceutical equipment.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a leading provider of life sciences and analytical instruments.

      3M COMPANY

      3M Company is a United States-based public company founded in 1902 with 60,500 employees. The company manufactures a diverse portfolio of products across multiple industries.

      PARKER HANNIFIN CORPORATION

      Parker Hannifin Corporation is a United States-based public company founded in 1917 with 57,950 employees. The company specializes in motion and control technologies.

      REPLIGEN CORPORATION

      Repligen Corporation is a United States-based public company founded in 1981 with 2,000 employees. The company provides bioprocessing solutions for the life sciences industry.

      ASAHI KASEI CORPORATION

      Asahi Kasei Corporation is a Japanese public company founded in 1922 with 47,895 employees. The company operates across chemicals, materials, and healthcare sectors.

      EATON CORPORATION PLC

      Eaton Corporation PLC is an Ireland-based public company founded in 1911 with 97,303 employees. The company provides diversified industrial power management solutions.

      GEA GROUP

      GEA Group is a German public company founded in 1881 with 19,670 employees. The company specializes in process technology and equipment for various industries.

      CORNING INCORPORATED

      Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees. The company manufactures specialty glass, ceramics, and related materials.

      DONALDSON COMPANY, INC.

      Donaldson Company, Inc. is a United States-based public company founded in 1915 with 15,000 employees. The company manufactures filtration systems and related products.

      SAINT-GOBAIN

      Saint-Gobain is a French public company founded in 1665 with 158,616 employees. The company is a global leader in building materials and high-performance materials.

      Reasons to Buy this Report

      • Market Entry Strategy for Mexico : Gain comprehensive insights into Mexico's pharmaceutical filtration landscape to develop targeted market entry strategies, identify key manufacturing clusters, and understand regulatory pathways specific to Mexican pharmaceutical operations.
      • Competitive Intelligence : Access detailed analysis of Mexico's competitive dynamics, including local and international players, market share distribution, and strategic partnerships within the Mexican pharmaceutical membrane filtration sector.
      • Investment Opportunity Assessment : Evaluate investment potential in Mexico's growing biopharmaceutical infrastructure with data-driven forecasts, growth drivers, and risk assessments specific to the Mexican market through 2029.
      • Supply Chain Optimization : Identify opportunities to optimize pharmaceutical supply chains by leveraging Mexico's manufacturing capabilities, understanding local supplier networks, and assessing nearshoring advantages for North American operations.
      • Technology Adoption Trends : Understand Mexico-specific adoption patterns for advanced membrane filtration technologies, including single-use systems, continuous processing, and automation trends driving pharmaceutical manufacturing modernization.

      Frequently asked questions

      What is the current size of Mexico's pharmaceutical membrane filtration market?

      Mexico's pharmaceutical membrane filtration market was valued at USD 96.7 million in 2024 and is projected to reach USD 155.8 million by 2029.

      What is the expected growth rate for Mexico's pharmaceutical membrane filtration market?

      Mexico's pharmaceutical membrane filtration market is expected to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2029.

      Why is Mexico's pharmaceutical membrane filtration market growing?

      Mexico's market is growing due to expansion of contract manufacturing organizations, increasing biopharmaceutical production, stricter regulatory compliance requirements, and modernization of pharmaceutical manufacturing infrastructure.

      What applications drive membrane filtration demand in Mexico?

      Key applications in Mexico include sterile drug formulation, biopharmaceutical processing, quality assurance testing, and compliance with international pharmaceutical manufacturing standards.

      How does Mexico's market compare to the broader Latin American region?

      Mexico represents a significant portion of Latin America's pharmaceutical membrane filtration market, driven by its advanced manufacturing capabilities, regulatory alignment, and role as a major pharmaceutical export hub.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global pharmaceutical membrane filtration market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research:

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical membrane filtration market. The secondary sources used for this study include American Membrane Technology Associations (AMTA), European Membrane Society (EMS),  American Association of Pharmaceutical Scientists (AAPS), Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), Parenteral Drug Association (PDA), Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, National Institutes of Health (NIH), World Health Organisation (WHO), Indian Pharmaceutical Association (IPA), International Society for Pharmaceutical Engineering (ISPE), BioProcess International Magazine, BioPharm International, Journal of Bioprocessing and Biotechniques, BioPlan Associates, ScienceDirect, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research:

      Extensive primary research was conducted after acquiring basic knowledge about the global pharmaceutical membrane filtration market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      The following is a breakdown of the primary respondents:

      Pharmaceutical Membrane Filtration Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation:

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical membrane filtration market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Bottom-up Approach:

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the pharmaceutical membrane filtration business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Pharmaceutical Membrane Filtration Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Top-down Approach:

      After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

      Pharmaceutical Membrane Filtration Market Size, and Share

      Data Triangulation:

      After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition:

      Membrane filtration is a process wherein solid particles present in a suspension are separated from a liquid or gas by employing membrane filters such as filter sheets, filter cartridges, or filter papers. These membrane filters are used to retain solids, thus allowing liquids to pass through. Membrane filters are used in pharmaceutical and biopharmaceutical manufacturing processes.

      Stakeholders:

      • Filter Manufacturers, Vendors, and Distributors
      • Academic and Government Research Institutes
      • Pharmaceutical and Biotechnology Companies
      • Life Science Companies
      • Venture Capitalists and Investors
      • Government Organizations
      • Private Research Firms
      • Contract Research Organizations (CROs)
      • Contract Development and Manufacturing Organizations (CDMOs)

      Report Objectives:

      • To define, describe, and forecast the global pharmaceutical membrane filtration market based on the product, technique, type, application, scale of operation and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities and challenges)
      • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall pharmaceutical membrane filtration market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the pharmaceutical membrane filtration market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment:

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

      Company Information:

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis:

      • A further breakdown of the Rest of Asia Pacific pharmaceutical membrane filtration market into countries
      • A further breakdown of the Rest of European pharmaceutical membrane filtration market into countries
      • A further breakdown of the Rest of Latin American pharmaceutical membrane filtration market into countries
      • A further breakdown of the Rest of Middle East pharmaceutical membrane filtration market into countries

      Get the Full Pharmaceutical Membrane Filtration Market Report

      Full forecast, segment splits, and company analysis for all Pharmaceutical Membrane Filtration Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status